The latest price target for KORU Medical Systems (NASDAQ:KRMD) was reported by Piper Sandler on February 14, 2025. The analyst firm set a price target for $4.50 expecting KRMD to rise to within 12 months (a possible 21.29% upside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for KORU Medical Systems (NASDAQ:KRMD) was provided by Piper Sandler, and KORU Medical Systems downgraded their neutral rating.

The last upgrade for KORU Medical Systems Inc happened on November 10, 2022 when Canaccord Genuity raised their price target to $4. Canaccord Genuity previously had a hold for KORU Medical Systems Inc.

The last downgrade for KORU Medical Systems Inc happened on February 14, 2025 when Piper Sandler changed their price target from $4.5 to $4.5 for KORU Medical Systems Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of KORU Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for KORU Medical Systems was filed on February 14, 2025 so you should expect the next rating to be made available sometime around February 14, 2026.

While ratings are subjective and will change, the latest KORU Medical Systems (KRMD) rating was a downgraded with a price target of $4.50 to $4.50. The current price KORU Medical Systems (KRMD) is trading at is $3.71, which is out of the analyst’s predicted range.